20/20 BioLab smanufactures and commercializes novel laboratory tests for the early detection and proactive treatment of chronic disease.
20/20 BioLabs has raised $749K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in December 2025.
20/20 BioLabs is headquartered in Gaithersburg, United States.
20/20 BioLab smanufactures and commercializes novel laboratory tests for the early detection and proactive treatment of chronic disease.
20/20 BioLabs is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"20/20 BioLabs — Funding & Investors." VCBacked, December 13, 2025, https://www.vcbacked.co/company/2020-biolabs. Accessed August 14, 2026.
VCBacked. (2025). 20/20 BioLabs — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/2020-biolabs
{{cite web |title=20/20 BioLabs — Funding & Investors |url=https://www.vcbacked.co/company/2020-biolabs |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated